Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Farkas

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Cancer Cell|September 13, 2022
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, John P Sfakianos, Daniel Ranti, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder CancerD Ranti, H Yu, Y A Wang, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Cancer Cell|September 13, 2022
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, John P Sfakianos, Daniel Ranti, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder CancerD Ranti, H Yu, Y A Wang, et al.
Pageof 18